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Abstract—Telemonitoring is emerging as a compelling 
application of Body Area Networks (BANs). We describe two 
health BAN systems developed respectively by a European team 
and an Australian team and discuss some issues encountered 
relating to formalization of clinical knowledge to support real-
time analysis and interpretation of BAN data. Our example 
application is an evidence-based telemonitoring and 
teletreatment application for home-based rehabilitation. The 
application is intended to support implementation of a clinical 
guideline for cardiac rehabilitation following myocardial 
infarction. In addition to this the proposal is to establish the 
patient’s individual baseline risk profile and, by real-time 
analysis of BAN data, continually re-assess the current risk level 
in order to give timely personalised feedback. Static and dynamic 
risk factors are derived from literature. Many sources express 
evidence probabilistically, suggesting a requirement for 
reasoning with uncertainty; elsewhere evidence requires 
qualitative reasoning: both familiar modes of reasoning in KBSs. 
However even at this knowledge acquisition stage some issues 
arise concerning how best to apply the clinical evidence. 
Furthermore, in cases where insufficient clinical evidence is 
currently available, telemonitoring can yield large collections of 
clinical data with the potential for data mining in order to 
furnish more statistically powerful and accurate clinical evidence. 
Keywords—Telemonitoring/treatment, Body Area Networks, 
personalised feedback, biosignal processing,  clinical guidelines. 
I.  INTRODUCTION 
Telemedicine services such as patient monitoring and 
treatment are emerging as some of the most compelling 
applications of Body Area Network (BAN) technology. In this 
paper we discuss two BAN-based telemedicine systems, one 
from Australia and one from Europe. The European team 
defined a generic Body Area Network as “a collection of (inter) 
communicating devices which are worn on the body, providing 
an integrated set of personalised services to the user” [1]. If 
these services are related to healthcare we call this 
specialization of the generic BAN a health BAN. Further 
specialization to a set of condition-specific services supporting 
a particular clinical application leads to a variety of specific 
health BANs such as a BAN to monitor cardiac arrhythmias 
(cardio-BAN), a pregnancy-monitoring BAN and so forth. 
Currently in the European Myotel project a BAN for providing 
myofeedback to chronic pain patients is being developed. Here 
the BAN devices are sensors for measuring surface EMG 
(electromyography), a local biofeedback device and a PDA 
which receives and processes sensor data and transmits it to a 
remote health professional via WiFi, GPRS and/or UMTS (see 
Fig. 1). The patient receives local feedback from the 
myofeedback BAN and remote feedback from the therapist 
with the aim of improving muscle relaxation and reducing pain. 
 
 
 
 
 
 
 
 
 
 
Fig. 1. European BAN for chronic pain patients  
In trials BAN data can simply be presented to the clinician 
as a visualisation, however large scale uptake of such m-health 
services necessitates automatic analysis and interpretation of 
 
biosignal data. At present we apply a procedural approach to 
biosignal interpretation, however we are beginning to 
investigate in what circumstances it is feasible and useful to 
apply AI technology to the problem of analysis and 
interpretation of BAN data. In this work-in-progress paper we 
refer to the example of dynamic risk assessment for patients 
undergoing cardiac rehabilitation, a new application being 
investigated by the Australian team. The intention is to build on 
current mobile monitoring systems for cardiac patients and 
develop a more intelligent, evidence-based monitoring and 
treatment application for home-based rehabilitation following 
myocardial infarction. The idea is that the cardiology team 
establishes the patient’s individual baseline risk profile and 
equips the patient with a cardiac rehabilitation BAN. This 
extension of the cardio-BAN incorporates a set of body worn 
sensors and transmits the captured biosignals to a remote 
healthcare location. Analysis of biosignals is performed locally 
on the BAN and/or remotely. As well as providing continuous 
cardiac monitoring, as the current systems do, the proposed 
BAN application will also continually reassess the patient’s 
current risk level, enabling the system and/or a remote clinician 
to give appropriate personalized, timely advice, support and if 
necessary, intervention. The intention is to support secondary 
prevention by optimizing rehabilitation activities and 
minimizing dynamic risk whilst maintaining vigilance in 
respect of adverse events or trends (the latter being already 
implemented in the existing cardio BANs). 
In section II we introduce the two existing health BAN 
systems, one from Sydney and one from Twente. Each has 
been prototyped and successfully trialled on different patient 
groups. In section III we outline the example application, 
namely personalised BAN-based support for patients in home-
based cardiac rehabilitation. This application could be 
implemented as an additional service running on either of the 
BAN systems. In section IV we discuss exercise during cardiac 
rehabilitation and in section V we raise some of the issues 
which were encountered in the knowledge acquisition phase. 
II. MOBILE MONITORING AND TREATMENT SYSTEMS  
First we describe the monitoring systems developed by two 
research groups. The Telemedicine Group at the University of 
Twente in The Netherlands and the Personal Health Monitor 
Group at the University of Technology, Sydney, are both 
researching the use of Body Area Networks to provide mobile 
health services to patients and health professionals. Both 
systems have been used successfully in trials with a number of 
different patient groups, with clinical applications and user 
requirements defined by the health professional users. Both the 
European BAN and the Australian BAN incorporate a set of 
body-worn devices including one or more sensors and a 
processing and communication platform (a mobile phone or 
PDA). Fig. 2 shows one variant of the European MobiHealth 
BAN [1-4] incorporating electrodes and respiration sensor and 
Fig. 3 shows the Australian PHM system [5-8] using in this 
case a blood pressure monitor and ECG.  
At Twente the emphasis has always been on telemedicine, 
ie. using “extraBAN” communication between the patient BAN 
and a remote healthcare organisation or clinician. A generic 
architecture for Body Area Networks (BANs) and a supporting 
m-health service platform have been developed, referred to 
respectively as the MobiHealth BAN and MobiHealth MSP. 
Based on the generic architecture, a series of specialised BANs 
and applications have been developed for different patient 
groups from a number of specialties including cardiology. 
 
Fig. 2. Another variant of the European MobiHealth BAN 
Biosignals measured by body worn sensors are transmitted 
to a remote healthcare location where they can be viewed by 
clinicians. Automated or clinician-initiated feedback and 
treatment completes the (macro) loop for BAN-based m-health 
services. Since 2002 several telemonitoring and teletreatment 
applications for a variety of (chronic and acute) clinical 
conditions have been trialled on different patient groups over 
the course of a number of collaborative projects (IST 
MobiHealth, IST XMotion, eTEN HealthService24, Freeband 
Awareness). The system is currently further developed to 
provide context aware teletreatment services in the eTEN 
project Myotel.  
The group at the University of Technology, Sydney, began 
researching a contrasting approach where the original emphasis 
was on local (micro-loop) processing, offering local monitoring 
                           
Fig. 3. Australian Personal Health Monitor 
 
and personalised services to patients to support self-care. The 
PHM has been trialled on 70 low-medium risk cardiac patients 
at the Sydney Royal North Shore Hospital (Cardiology 
Department) in Australia and is currently under commercial 
development. An extensive description and comparison of the 
two systems (European and Australian) can be found in [9]. 
Both the European and Australian systems can be classed 
as health BANs according to the definition given in Section I. 
In both systems captured biosignals undergo a series of 
processes starting with low level signal processing and ending 
with high level clinical analysis and interpretation to various 
levels of abstraction in order, for example, to detect medical 
emergencies or adverse trends. Both include detection of 
cardiac arrhythmias as one of the offered clinical applications.  
  The sensors currently integrated into the Personal Health 
Monitor are: ECG, weight scale, accelerometer, blood pressure 
monitor, blood glucose meter, pulse oximeter and GPS. The 
sensors that have been integrated into the MobiHealth BAN to 
date are: electrodes for measuring 3, 4 and 9 channel ECG and 
surface EMG,  pulse oximeter, respiration sensor, temperature 
sensor and activity sensors (step-counter, 3D accelerometer). 
For certain clinical interpretation tasks, such as detecting 
when certain pre-specified thresholds are exceeded, a 
procedural approach suffices. Other interpretation tasks require 
a more sophisticated approach, involving fusion and analysis of 
data from multiple sensors. At a certain point procedural 
approaches may not be the best solution and both research 
groups have come to realize the necessity, in some 
applications, of moving to a knowledge-based approach and 
incorporating context awareness to the analysis and 
interpretation of BAN data [10-12, 3]. In the next section we 
describe the cardiac rehabilitation application; this is a new 
application and we stress that we are currently only in the 
knowledge acquisition phase. This new variant of the BAN has 
not yet been developed. 
III. EXAMPLE: CARDIAC REHABILITATION BAN  
Participation in cardiac rehabilitation programmes post MI  
(myocardial infarction) “has been shown to reduce all-cause 
mortality and cardiac mortality when compared to usual care” 
[13]. The vision of [14] was to implement continuous risk 
assessment for this patient group by means of intelligent real-
time analysis and interpretation of BAN-captured biosignals 
together with context data. As well as detecting clinical 
emergencies and trends this extended cardiology BAN would 
estimate the current risk level and give personalised feedback 
and encouragement to support compliance (eg exercise and 
medication reminders) to the patient. The advice would attempt 
to minimize personal risk levels at any one time for example by 
rescheduling exercise not to coincide with elevation of risk 
levels caused by other factors such as stress. 
The American Heart Association lists the major non-
modifiable risk factors for cardiovascular disease as: age, 
gender and heredity (family history, race). These factors play a 
major part in determining an individual patient’s baseline risk. 
The major modifiable risk factors (cigarette smoking, obesity, 
hypertension, high blood cholesterol, diabetes mellitus and 
physical inactivity) can be influenced by life-style changes 
and/or medication. However the impact of changes in lifestyle 
will usually be gradual (over weeks or months). Risk of 
mortality by myocardial infarction or coronary heart disease 
can be estimated based on these modifiable and non-modifiable 
risk factors. Risk is usually expressed in terms of percentage of 
mortality over a 10 year time span [15]. Other so-called 
“contributory factors” are stress, alcohol, diet and nutrition, but 
“their significance and prevalence haven't yet been precisely 
determined” [15]. In addition to the static or relatively slowly 
changing factors, the literature also refers to factors elevating 
risk in the short term. These ‘triggers’ include time of day, 
physical exertion, weekly and seasonal variations, eating a 
heavy meal, smoking and “meteorological stress” (ie exposure 
to extreme temperatures). All these triggers may lead to 
ischaemia, which could be detected directly through ST 
segment changes on the ECG. However we did not find an 
algorithm for detecting ST segment changes that could be 
implemented on the BAN at present.  
The proposal was to extend the existing cardiology BAN 
from Sydney (the PHM system) and its software in order to 
monitor, where possible, these short term risk factors and 
dynamically estimate the changing risk for an individual 
patient. (The proposed application could similarly be 
implemented by extension of the European MobiHealth cardio-
BAN.) The baseline risk would be set and regularly reviewed 
by the cardiologist and the system would calculate the dynamic 
risk on the basis of sensor data and context information and 
give appropriate feedback. The cardiac rehabilitation BAN 
proposed in [14] would consist of an extension of the PHM 
system, consisting of a processing platform (a mobile phone) 
which communicates wirelessly with sensors and context 
sources to continuously update the current risk estimate. The 
sensors would be electrodes (to measure ECG and derive heart 
rate), accelerometer (to detect falls and to measure duration and 
intensity of physical activity), temperature sensor and blood 
pressure monitor. Context sources would include the internal 
clock of the mobile phone (time of day) and calendar (for 
seasonal variation in risk). For some factors the patient would 
be required to enter data (eg. heavy meal, cigarette), since not 
all dynamic risk factors identified can currently be measured 
using existing sensors or external context sources. 
At Sydney a first selection of static and dynamic risk 
factors was established following a literature search and a first 
attempt at formalisation of the knowledge was attempted, 
resulting in a model for dynamic risk assessment and an 
algorithm incorporating a scoring system [16]. The concept 
was to define a personal baseline risk based on the 
cardiologist’s assessment including the particular fixed and 
voluntary characteristics of the individual patient, and then on a 
moment-by-moment basis to dynamically increment or 
decrement the current risk score according to changing factors 
known to influence risk in the short term. SCORE risk 
functions [17] were preferred over Framingham [18] since the 
target group are already diagnosed with cardiac disease or have 
suffered a cardiac event. The resulting model can be regarded 
as a first approximation based on a literature search only, still 
requiring validation by clinical experts. However even at this 
early stage many issues emerged; here we discuss some points 
arising from the evidence relating to the role of exercise during 
rehabilitation. 
IV.   EXERCISE DURING CARDIAC REHABILITATION 
Exercise is a central component in cardiac rehabilitation. 
The NICE clinical guideline on secondary prevention 
following a myocardial infarction includes as a key priority that 
“Patients should be advised to undertake regular physical 
activity sufficient to increase exercise capacity” and that 
“Patients should be advised to be physically active for 20–30 
minutes a day to the point of slight breathlessness” [13]. Some 
health authorities offer a hospital-based rehabilitation 
programme including exercise sessions which are monitored 
closely by clinical staff. According to the definition of phases 
of comprehensive cardiac rehabilitation found in the UK 
National Service Framework for Coronary Heart Disease, 
(Appendix F of the full guideline [13]), “structured exercise 
sessions to meet the assessed needs of individual patients” are 
introduced for eligible patients in Phase 3 of rehabilitation, four 
weeks after the acute cardiac event. Since physical exertion 
itself can be a trigger for further cardiac events, the exercise 
prescription must be adapted to the individual patient and 
carefully monitored. Phase 3 is usually implemented as a 
hospital based outpatient programme. After this phase, exercise 
and other lifestyle recommendations will be made for Phase 4: 
“long-term maintenance of changed behaviour”. Long term 
regular exercise has been “shown to reduce all-cause and 
cardiac mortality in patients after an MI” [13]. However the 
guideline notes that “Maintenance of these lifestyle changes in 
patients after an MI has been shown to decline following the 
end of the patient’s participation in coordinated comprehensive 
cardiac rehabilitation” and identifies the key research question: 
“What encourages the maintenance of regular exercise … 
beyond the period of comprehensive cardiac rehabilitation?”  
We investigate whether a BAN-based monitoring 
application could additionally provide patients in Phase 4 with 
support in maintaining and optimizing their long term home-
based rehabilitation by tracking and helping to minimize 
personal dynamic risk levels and by giving personalised 
feedback, encouragement, reassurance and a sense of safety.  
Currently we are examining the complex set of rules in [16] 
to see if a Clinical Decision Support (CDS) approach could 
offer a better solution than the procedural approach.  
V. DISCUSSION AND CONCLUSIONS 
The preparatory work to date on the cardiac rehabilitation 
application has been largely concerned with the knowledge 
acquisition phase, involving searches of the medical literature 
including relevant clinical guidelines to provide the base 
clinical knowledge. Knowledge engineering was initially 
attempted by expressing individual risk factors in rules and 
procedures using flowcharts and a scoring system. The rules, 
which are quite complex, can be found in [16]. Currently we 
investigate expressing the knowledge in a suitable KR 
formalism for processing using CDSS technology to analyse 
and interpret BAN data and context data. Some issues we 
encountered are outlined below. 
Degrees of uncertainty.  Probabilistic evidence on some of 
the risk factors is sometimes expressed with large ranges, 
variance or margins of error. An example is the estimation of 
ventilatory threshold based on HRmax. The threshold is used in 
one of the rules in [16]. At first sight this appears to be a simple 
question of estimating and applying a threshold. Although both 
ventilatory threshold and HRmax can be measured directly by a 
cardiac stress test, such tests are inadvisable in post-MI patients 
(indeed this would violate the rules in which they are 
referenced). Therefore an estimate is used in [16] where 
ventilatory threshold is estimated on the basis of HRmax, which 
is in turn estimated by the formula commonly used in exercise 
physiology of 220 minus age in years. However this HRmax 
formula has been criticised (eg. in [18]) as being clinically 
unfounded: “Research since 1971 has revealed the error in 
HRmax estimation, and there remains no formula that provides 
acceptable accuracy of HRmax prediction.” A number of 
alternative formulae are reviewed in [18], but the conclusion is 
that more research is required to establish a more accurate 
method of estimation. Furthermore, the formula for estimating 
ventilatory threshold in relation to HRmax is itself expressed 
with a wide margin of variability:  “The ventilatory threshold 
corresponds with approximately 85% of HRmax. But this may 
vary between 50% and 90% of HRmax” [16]. The concern is 
that such high degrees of uncertainty or imprecision will 
multiply up casting doubt on the likelihood of reaching useful 
conclusions.  
Another point is general lack of consensus over risk factors 
“Risk factors for cardiovascular disease have been defined by 
various groups and experts for decades. Unfortunately, the lack 
of consensus among these groups and the periodic changes in 
risk factor listings have led to confusion among health care 
professionals” [19]. 
Finally separate items of clinical evidence, often expressed 
probabilistically, were found in the literature but the issue of 
finding evidence supporting how to combine, normalize and 
weight these separate items however seems to us to be 
problematic, and the weights assigned in [16] were in many 
cases arbitrary first ‘guesstimates’. We feel the need for expert 
opinion or further evidence in order to combine, normalize, 
weight and tune the knowledge base relating to the different 
risk factors. 
To summarise this work-in-progress, we pose the general 
question: in what circumstances it is feasible and useful to 
incorporate knowledge based systems into BAN monitoring 
and treatment applications? Further, in the particular case of 
real-time cardiac risk assessment, we ask if the cardiac 
rehabilitation BAN concept itself is clinically valid, useful and 
achievable given present knowledge and technology. If the 
concept is valid, we see potential for cost efficient delivery of 
effective cardiac rehabilitation. NHS Lothian’s Heart Manual 
programme has demonstrated that properly planned and 
managed home-based cardiac rehabilitation can be as effective 
as hospital-based rehabilitation programmes [21]. Augmenting 
this with real-time monitoring and feedback systems for home 
use by patients could further enhance such home-based 
programmes, hence the proposed BAN-supported home-based 
rehabilitation application might have the potential not only to 
support Phase 4 cardiac rehabilitation, but possibly to replace 
the hospital-based Phase 3 of current programmes. The 
application also has potential for monitoring health under 
extreme circumstances, eg. for deep sea divers repairing oil 
pipe lines, or workers at high altitude, athletes in training or 
military personnel on the battlefield. In Twente we also 
investigate an application of CDSSs using Actor-Agent 
Communities (AAC) based on Bayesian networks.  That study 
[22] focuses on rehabilitation for chronic pain patients. 
If the concept is valid, but (in the cardiac rehabilitation 
application or other applications) insufficient clinical evidence 
is currently available to support the application, an alternative 
contribution by our technology might be found in data 
aggregation. Data routinely collected from patient health BANs 
can furnish large collections of clinical data with the potential 
for data mining in order to yield more statistically powerful and 
accurate clinical evidence. Such data aggregation effort 
however requires standards relating to representation of 
biosignal data and the associated metadata needed to compare 
and interpret them. 
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